# Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext

> **NCT01887405** · PHASE4 · COMPLETED · sponsor: **ALK Nordic A/S, Danmark Filial** · enrollment: 91 (actual)

## Conditions studied

- Handling of Auto-injectors

## Interventions

- **DRUG:** Adrenaline auto-injector

## Key facts

- **NCT ID:** NCT01887405
- **Lead sponsor:** ALK Nordic A/S, Danmark Filial
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887405, "Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01887405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*